Defecetive Drugs: adrugrecall.com

NEWS®

We Can Help.

Contact Us Today

Use this form to request a free consultation with a qualified attorney near you.

ATTORNEY ADVERTISING -

Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.

Pfizer voluntarily withdraws Bextra from New Zealand market

-April 12, 2005

Pfizer has voluntarily withdrawn Bextra from the New Zealand market. Last week, the U.S. Food and Drug Administration asked Pfizer to remove Bextra from the market after deciding the risks of using Bextra outweigh its benefits, though Pfizer disagreed with the agency's request. Bextra is linked to increased risks of heart attacks and strokes, like all COX-2 inhibitors, in addition to a potentially deadly skin disease called Stevens Johnson syndrome.

For more information on bextra, please contact us.

More Recent Defective Drug News

More Issues

Legal Marketing Website designed and developed by: eJustice.com

ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.